• Strategic PARP Inhibition: MK-4827 (Niraparib) in Translatio

  2026-06-04

  This thought-leadership article examines the mechanistic underpinnings and translational potential of MK-4827 (Niraparib), a selective PARP-1/-2 inhibitor, in the evolving landscape of cancer research. By integrating recent advances in overcoming resistance, especially in the context of chemotherapy and BRCA-mutated cancers, we provide actionable guidance for translational researchers seeking to maximize the therapeutic impact of DNA damage repair inhibition strategies.

• Budesonide (SKU B1900): Reliable Anti-Inflammatory for Lab M

  2026-06-03

  This article provides scenario-driven, evidence-based guidance for researchers using Budesonide (SKU B1900) in cell viability, proliferation, and cytotoxicity assays. Drawing upon validated protocols and quantitative data, we explore how APExBIO's Budesonide ensures experimental reproducibility and interpretive clarity in respiratory disease research.

• Ziprasidone HCl: Bridging Psychiatry and Oncology Research

  2026-06-03

  Explore how Ziprasidone Hydrochloride (Ziprasidone HCl) is catalyzing a paradigm shift in translational research by uniting dopaminergic and serotonergic pathway modulation with innovative antitumor strategies. This thought-leadership article delivers mechanistic clarity, experimental best practices, and actionable guidance for researchers aiming to leverage APExBIO’s Ziprasidone HCl in both neuroscience and cancer studies.

• Streptavidin-HyperFluor 647: High-Sensitivity Biotin Detecti

  2026-06-02

  Streptavidin-HyperFluor 647 is a Streptavidin fluorescent conjugate optimized for sensitive detection of biotinylated molecules. Its low non-specific binding profile and bright red emission make it ideal for fluorescence microscopy and flow cytometry. APExBIO's K4406 kit offers robust, stable performance for advanced biotin detection workflows.

• Mitomycin C: Antitumor Antibiotic Workflows in Cancer Resear

  2026-06-02

  Mitomycin C stands out as a robust antitumor antibiotic for apoptosis and DNA replication inhibition studies. This guide details actionable workflows, quantitative protocol parameters, and troubleshooting strategies, empowering researchers to leverage APExBIO’s Mitomycin C for high-fidelity cancer research—including p53-independent apoptosis signaling and combination therapy optimization.

• ABT-888 (Veliparib): Optimizing DNA Repair Inhibition Workfl

  2026-06-01

  Harness the potency of ABT-888 (Veliparib) to strategically sensitize cancer cells to chemotherapy and radiation in microsatellite instability (MSI) tumor models. This guide translates cutting-edge DNA repair inhibition science into actionable workflows, troubleshooting tips, and comparative insights for preclinical research.

• AM 281: Advancing CB1 Cannabinoid Receptor Antagonist Assays

  2026-06-01

  AM 281 offers unmatched selectivity for the CB1 cannabinoid receptor, making it an indispensable tool for dissecting neuroprotection and memory impairment mechanisms in preclinical research. By leveraging recent insights into the CB1-CREB-GLT-1 axis, AM 281 enables robust modeling of traumatic brain injury and cognitive dysfunction, with protocol flexibility and troubleshooting strategies that maximize reproducibility.

• Superoxide Dismutase (SOD) Activity Assay Kit: Technical Gui

  2026-05-31

  The Superoxide Dismutase (SOD) Activity Assay Kit (K2035) enables reliable quantification of SOD enzyme activity in biological fluids, supporting research into oxidative stress and antioxidative defense. This kit is not intended for diagnostic or clinical purposes and should be used within its validated range for biochemical assays.

• Pepstatin A: Aspartic Protease Inhibitor for Precision Assay

  2026-05-30

  Pepstatin A from APExBIO delivers unmatched specificity in aspartic protease inhibition, streamlining workflows from HIV replication studies to osteoclast differentiation inhibition. This article details optimized protocols, troubleshooting insights, and advanced use-cases to maximize research reproducibility and impact.

• Vancomycin Hydrochloride: Advanced Research Applications & I

  2026-05-29

  Explore the scientific foundations and innovative uses of Vancomycin hydrochloride, a leading glycopeptide antibacterial agent, in high-impact microbiological and resistance studies. This article reveals advanced mechanisms, unique assay strategies, and translational research perspectives not covered elsewhere.

• Troglitazone: Unraveling PPARγ-Driven SPP1 Modulation in Tum

  2026-05-29

  Explore Troglitazone as a PPARγ agonist for innovative SPP1 and TAM modulation in cancer research. This article delivers unique mechanistic insights and practical protocol guidance, bridging metabolic and immuno-oncology domains.

• Caveolin-1 Modulates Cholesterol Homeostasis in MASLD Progre

  2026-05-28

  This study reveals that Caveolin-1 (CAV1) plays a protective role in metabolic dysfunction-associated steatotic liver disease (MASLD) by restoring cholesterol homeostasis, thereby reducing endoplasmic reticulum stress and hepatocyte pyroptosis. The findings highlight CAV1 as a crucial regulator in the pathogenesis of MASLD and suggest that targeting cholesterol accumulation may offer therapeutic benefit.

• Filipin III: Advanced Cholesterol Profiling in Membrane Rese

  2026-05-28

  Discover how Filipin III, a polyene macrolide antibiotic, enables advanced, quantitative mapping of cholesterol in cellular membranes. This article reveals new assay strategies and reference-driven insights for researchers seeking deeper mechanistic understanding.

• Paclitaxel (Taxol): Precision Modeling of Chemotherapy-Induc

  2026-05-27

  Explore the unique role of Paclitaxel (Taxol) in modeling chemotherapy-induced peripheral neuropathy and advancing cancer research. This article reveals novel cross-domain insights and practical workflow guidance for biomedical investigators.

• TCAIM-Mediated OGDH Regulation Reveals New Mitochondrial Con

  2026-05-27

  The referenced study uncovers TCAIM as a mitochondrial DNAJC co-chaperone that selectively binds and reduces α-ketoglutarate dehydrogenase (OGDH) levels, suppressing TCA cycle activity. This discovery highlights a novel post-translational mechanism for metabolic regulation and advances understanding of mitochondrial proteostasis in cellular metabolism.

453 records 16/31 page Previous Next First page 上5页 1617181920 下5页 Last page